In addition, the combination of STAT3 inhibitor (i.e., AZD1480) and VEGF inhibitor (i.e., cediranib) significantly reduced GBM volume and microvessel density in murine xenograft models of GBM (de Groot et al., 2012). Here, VEGFA is linked to glioblastoma.